All News #Library
Quality
FDA doles out yet another Form 483 to troubled Alvotech
22 Jan 2024 //
FIERCE PHARMA
Alvotech Provides Update on Status of U.S. BLA for AVT04
13 Oct 2023 //
PRESS RELEASE
Alvotech resubmits its interchangeable Humira biosim AbbVie clings
31 Aug 2023 //
ENDPTS
Alvotech receives another CRL from the FDA for Humira biosimilar candidate
30 Jun 2023 //
ENDPTS

Market Place
Sourcing Support